Article

QPSOBT: One codon usage optimization software for protein heterologous expression

Key Laboratory of Industrial Biotechnology, School of Biotechnology, JiangNan University, 214122, Wuxi, Jiangsu, China; School of Information Technology, JiangNan University, 214122, Wuxi, Jiangsu, China
Journal of Bioinformatics and Sequence Analysis 07/2010; 2:25-29.

ABSTRACT QPSOBT is a codon usage optimization software based on the Quantum-behaved Particle Swarm Optimization (QPSO) algorithm. It can design synthetic genes of multikilobase sequences for protein heterologous expression rapidly. The program runs on .NET platform. Compared to the existing codon optimization software and web services, QPSOBT is able to generate better results when DNA/RNA sequence length is less than 6 kb which is a commonly-used range, especially when some restriction sites need to be removed. QPSOBT is freely available (www.sigcib.org/qpsobt.html).

0 Bookmarks
 · 
408 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: The construction of customized nucleic acid sequences allows us to have greater flexibility in gene design for recombinant protein expression. Among the various parameters considered for such DNA sequence design, individual codon usage (ICU) has been implicated as one of the most crucial factors affecting mRNA translational efficiency. However, previous works have also reported the significant influence of codon pair usage, also known as codon context (CC), on the level of protein expression. RESULTS: In this study, we have developed novel computational procedures for evaluating the relative importance of optimizing ICU and CC for enhancing protein expression. By formulating appropriate mathematical expressions to quantify the ICU and CC fitness of a coding sequence, optimization procedures based on genetic algorithm were employed to maximize its ICU and/or CC fitness. Surprisingly, the in silico validation of the resultant optimized DNA sequences for Escherichia coli, Lactococcus lactis, Pichia pastoris and Saccharomyces cerevisiae suggests that CC is a more relevant design criterion than the commonly considered ICU. CONCLUSIONS: The proposed CC optimization framework can complement and enhance the capabilities of current gene design tools, with potential applications to heterologous protein production and even vaccine development in synthetic biotechnology.
    BMC Systems Biology 10/2012; 6(1):134. · 2.98 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Gene expression is closely related to optimal vector-host system pairing in many prokaryotes. Redesign of the human cystatin C (cysC) gene using the preferred codons of the prokaryotic system may significantly increase cysC expression in Escherichia coli (E. coli). Specifically, cysC expression may be increased by removing unstable sequences and optimizing GC content. According to E. coli expression system codon preferences, the gene sequence was optimized while the amino acid sequence was maintained. The codon-optimized cysC (co-cysC) and wild-type cysC (wt-cysC) were expressed by cloning the genes into a pET-30a plasmid, thus transforming the recombinant plasmid into E. coli BL21. Before and after the optimization process, the prokaryotic expression vector and host bacteria were examined for protein expression and biological activation of CysC. The recombinant proteins in the lysate of the transformed bacteria were purified using Ni(2+)-NTA resin. Recombinant protein expression increased from 10% to 46% based on total protein expression after codon optimization. Recombinant CysC purity was above 95%. The significant increase in cysC expression in E. coli expression produced by codon optimization techniques may be applicable to commercial production systems.
    BioMed Research International 01/2012; 2012:732017. · 2.71 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: H I G H L I G H T S c Developed in silico rational framework for synthetic terpenoid production. c Updated metabolic model of A. thaliana to describe terpenoid biosynthesis. c Analyzed heterologous expression of A. thaliana pathways in microbial systems. c Proposed novel in silico method of cofactor modification analysis. c Improve terpenoid yield by modifying enzyme cofactor specificity. a b s t r a c t Terpenoids are a large and diverse group of plant secondary metabolites with important applications in the pharmaceutical, cosmetic and food industries. However, low yields obtained from natural plant sources necessitate the search for alternative ways to increase the throughput of terpenoid production. Thus, fast-growing microbial systems, such as Escherichia coli and Saccharomyces cerevisiae, can be genetically engineered to achieve high productivity by systematically designing terpenoid synthetic routes and improving its precursor, isopentenyl diphosphate (IPP) production. To this end, we develop an in silico model-based rational framework where the cellular metabolism in natural terpenoid producer is analyzed to provide a basis for designing its synthetic pathways in microbial hosts. At the outset, we updated the genome-scale Arabidopsis thaliana metabolic model to characterize optimal metabolic utilization patterns that were subsequently incorporated into the in silico models of microbial hosts for improving terpenoid yield. We also developed a novel computational approach, cofactor modification analysis (CMA), to tackle potential limitations in terpenoid production caused by suboptimal balance of the different redox cofactors. The enzyme targets identified by CMA can potentially lead to better metabolic engineering strategies for enhancing terpenoid production in microbial systems.
    Chemical Engineering Science 09/2012; · 2.61 Impact Factor

Full-text (3 Sources)

View
67 Downloads
Available from
Oct 8, 2014